Pursue a “Biology First” approach to choose the right targets and tools
At Amgen, we believe drug discovery starts with a deep understanding of biology. This understanding guides the critical choice of which disease target to...
Refocus and differentiate our Discovery Research efforts
At a time when technological breakthroughs are revolutionizing how drugs are discovered, Amgen's strategy aims to fully exploit the emerging opportunities. We have made...
Ensure major investments are based on compelling science
Many companies in our industry have pursued a strategy known as "Shots on Goal," where the aim is to maximize the number of molecules...
Ventana to collaborate with Boehringer Ingelheim on the development of companion diagnostic tests
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, and Boehringer Ingelheim (BI) announced today that they have entered into an agreement...
Circuit Therapeutics and Boehringer Ingelheim announce signature of a research partnership agreement to discover new approaches to treating psychiatric disorders
Boehringer Ingelheim and Circuit Therapeutics have entered into a research collaboration agreement for the discovery of new ways of treating psychiatric disorders. Circuit Therapeutics...
Crystal Bioscience and Boehringer Ingelheim Announce Multiple Target Antibody Discovery Collaboration
Crystal Bioscience Inc. (Crystal) and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the discovery and development of...
Hydra Biosciences and Boehringer Ingelheim announce worldwide collaboration to develop small-molecule inhibitors for the treatment of central nervous system diseases and disorders
Hydra Biosciences, Inc., a leader in the field of Transient Receptor Potential (TRP) channel modulation, and Boehringer Ingelheim, one of the world’s leading pharmaceutical...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...